Chapter PDF
References
Abele-Horn, M., Busch, U., Nitschko, H., Jacobs, E., Bax, R., Pfaff, F, Schaffer, B., & Heesemann, J. (1998). Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J. Clin. Microbiol., 36, 548–551.
Alexander, E. R., Foy, H. M., Kenny, G. E., Kronmal, R. A., McMahan, R., Clerke, E. R., MacColl, W. A., & Grayston, J. T. (1966). Pneumonias due to Mycoplasma pneumoniae. N. Engl. J. Med., 275, 131–136.
Bartlett, J. G., Breiman, R. F., Mandell, L. A., File, T. M. Jr., Mustier, D. M., & Fine, M. J. (2000). Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis., 31, 347–382.
Baseman, J. B., & Tully, J. G. (1997). Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis., 3, 21–32.
Baum, S. G. (1995). Mycoplasma pneumoniae and atypical pneumonia, in: Principles and Practice of Infectious Diseases (G. L. Mandell, J. E. Bennett, & R. Dolin, eds.). New York: Churchill Livingstone, pp. 1704–1713.
Bébéar, C., Dupon, M., Renaudin, H., & de Barbeyrac, B. (1993). Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin. Infect. Dis., 17(Suppl. 1), S202–S207.
Block, S., Hedrick, J., Hammerschlag, M. R., Cassell, G. H., & Craft, J. C. (1995). Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspensions in the treatment of children with community-acquired pneumonia. Pediatr. Infect. Dis. J., 14, 471–477.
Cartner, S. C., Simecka, J. W., Lindsey, J. R., Cassell, G. H., & Davis, J. K. (1995). Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and anti-body response. Infect. Immun., 63, 4138–4142.
Cassell, G. H. (1982). The pathogenic potential of mycoplasmas. Rev. Infect. Dis., 4(Suppl.), S18–S34.
Cassell, G. H. (1995). Severe Mycoplasma disease—rare or underdiagnosed? West. J. Med., 162, 172–175.
Cassell, G. H., Drnec, J., Waites, K. B., Pate, M. S., Duffy, L. B., Watson, H. L., McIntosh, J. C. (1991). Efficacy of clarithromycin against Mycoplasinu pneumoniae. J. Antimicrob. Chemother., 27(Suppl A), 47–59.
Chan, E. D., & Welsh, C. H. (1995). Fulminant Mycoplasma pneumoniae pneumonia. West J. Med., 162, 133–142.
Cherry, J. D. (1993). Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin. Infect. Dis., 17(Suppl. 1), S47–S51.
Chiou, C. C., Liu, Y. C., Lin, H. H., & Hsieh, K. S. (1997). Mycoplasma pneumoniae infection complicated by lung abscess, pleural effusion, thrombocytopenia and disseminated intravascular coagulation. Pediatr. Infect. Dis. J., 16, 327–329.
Cimolai, N., Wensley D., Seear M., & Thomas E. T. (1995). Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin. Infect. Dis., 21, 1182–1185.
Clyde, W. A. Jr. (1993). Clinical overview of typical Mycoplasma pneumoniae infections. Clin. Infect. Dis., 17(Suppl. 2), S32–S36.
Cunha, B. A., & Ortega, A. M. (1996). Atypical pneumonia: extrapulmonary clues guide the way to diagnosis. Postgrad. Med., 99, 123–132.
de Barbeyrac, B., Bernet-Poggi, C., Fébrer, F, Renaudin, H., Dupon, M., & Bébéar, C. (1993). Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction. Clin. Infect. Dis., 17 (Suppl. 1), S83–S89.
Eaton, M. D., Meiklejohn, G., & VanHerick, W. (1944). Studies on the etiology of primary atypical pneumonia: a filtrable agent transmissible to cotton rats, hamsters and chick embryos. J. Exp. Med., 79, 649–668.
Falguera, M., Nogues, A., Ruiz-Gonzalez, A., Garcia, M., & Puig, T. (1996). Detection of Mycoplasma pneumoniae by polymerase chain reaction in lung aspirates from patients with community-acquired pneumonia. Chest, 110, 972–976.
Fang, G. D., Fine, M., Orloff, J., Arisumi, D., Yu, V. L., Kapoor, W., Grayston, J. T, Wang, S. P., Kohler, R., Muder, R. R., Ying, C. Y., Rihs, J. D., & Vickers, B. S. (1990). New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine, 69, 307–316.
Farr, B. M., Kaiser, D. L., Harrison, B. D. W., & Connolly, C. K. (1989). Prediction of microbial etiology at admission to hospital for pneumonia from the presenting clinical features. Thorax, 44, 1031–1035.
Farraj, R. S., McCully, R. B., Oh, J. K., & Smith, T. F. (1997). Mycoplasma-associated pericarditis. Mayo Clin. Proc., 72, 33–36.
Ferraro, M. J. (1997). Limitations in laboratory diagnosis of community-acquired pneumonia and acute exacerbations of chromic bronchitis. Hosp. Med., 33(Suppl. 2), 14–17.
File, T. M. Jr, Tan, J. S., & Plouffe, J. F. (1996). Community-acquired pneumonia—what’s needed for accurate diagnosis. Postgrad. Med., 99, 95–107.
File, T. M. Jr., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R., Kojak, C., & Rubin, A. (1997). A multicenter randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother., 41, 1965–1972.
File, T. M. Jr., Tan, J. S., & Plouffe, J. F. (1998). The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect. Dis. Clin. North Am., 12, 569–592.
Fine, M. J., Smith, M. A., Carson, C. A., Sunita, S. M, Sankey, S. S., Weissfield, L. A., & Kapoor, W. N. (1996). Prognosis and outcome of patients with community-acquired pneumonia: a meta-analysis. JAMA, 275, 134–141.
Foy, H. M. (1993). Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis., 17(Suppl. 1), S37–S46.
Foy, H. M., Kenny, G. E., McMahan, R., Mansy, A. M., & Grayston, J. T. (1970). Mycoplasma pneumoniae pneumonia in an urban area: five years of surveillance. JAMA, 214, 1666–1672.
Foy, H. M., Kenny, G. E., Cooney, M. K., & Allan, I. D. (1979). Long-term epidemiology of infections with Mycoplasma pneumoniae. J. Infect. Dis., 139, 681–687.
Gray, G. C., Duffy, L. B., Paver, R. J., Putnam, S. D., Reynolds, R. J., & Cassell, G. H. (1997). Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in Southern California. Military Med., 162, 524–526.
Gregory, W. W., Rosenstein, R. B., Flouty, C. E., Mellis, S. J., & the Atypical Pneumonia Study Group. (1997). Azithromycin in the treatment of community-acquired pneumonia (CAP) due to Mycoplasma pneumoniae or Chlamydia pneumoniae. Abstract presented as a poster at the American Thoracic Society, May 17–21, San Francisco, CA.
Hammerschlag, M. R. (1995). Atypical pneumonias in children. Adv. Pediatr. Infect. Dis., 10, 1–38.
Hwang, J.-J., Chen, K.-L., Tsai, M.-S., Huang, M.-S., Wang, T.-H., Lin, M.-S., Chong, I.-W., Hwang, K.-P, Wu, J.-R., & Huang, T.-Y. (1993). Clinical study of Mycoplasma pneumoniae pneumonia. Kaohsiung J. Med. Sci., 9, 204–211.
Jacobs, E. (1993). Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin. Infect. Dis., 17(Suppl. I), S79–S82.
Janssens, J-P, Gauthey, L., Herrmann, F., Tkatch, L., & Michel, J. P. (1996). Community-acquired pneumonia in older patients. J. Am. Geriatr. Soc., 44, 539–544.
Kenny, G. E., & Cartwright, F. D. (1996). Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin. Antimicrob. Agents Chemother., 40, 1048–1049.
Kenny, G. E., Kaiser, G. G., Cooney, M. K., & Foy, H. M. (1990). Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J. Clin. Microbiol, 28, 2087–2093.
Kenney, R. T., Li, J. S., Clyde, W. A. Jr., Wall, T. C., O’Connor, C. M., Campbell, P. T., Trigt, P. V., & Corey, G. R. (1993). Mycoplasmal pericarditis: evidence of invasive disease. Clin. Infect. Dis., 17(Suppl. 1), S58–S62.
Koshiniemi, M. (1993). CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin. Infect. Dis., 17(Suppl. 1), S52–S57.
Laitinen, L. A., Miettinen, A. K., Kuosma, E., Huhtala, L., & Lehtomäki, K. (1992). Lung function impairment following mycoplasmal and other acute pneumonias. Eur. Respir. J., 5, 670–674.
Lehtomäki, K., Kleemola, M., Tukianen, P., Kantanen, M.-L., & Laitinen, L. A. (1987). Isolation of Mycoplasma pneumoniae from bronchoalveolar lavage fluid. J. Infect. Dis., 155, 1339–1341.
Lieberman, D., Schlaeffer, F., Boldur, I., Lieberman, D., Horowitz, S., Friedman, M. G., Leiononen, M., Horovitz, O., Manor, E., & Porath A. (1996a). Multiple pathogens in adult patients admitted with community-acquired pneumonia; a one year prospective of 346 consecutive patients. Thorax, 51, 179–184.
Lieberman, D., Schlaeffer, F., Lieberman, D., Horowitz, S., Horvitz, O., & Porath, A. (1996b). Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration, 63, 261–266.
Lim, I., Shaw, D. R., Stanley, D. P., Lumb, R., & McLennan, G. (1989). A prospective study of the aetiology of community-acquired pneumonia. Med. J. Aust., 151, 87–91.
Liu, C. (1994). Mycoplasmal pneumonia. Infect. Dis., 5, 411–416.
Llibre, J. M., Urban, A., Garcia, E., Carrasco, M. A., & Murcia, C. (1997). Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin. Infect. Dis., 25, 1340–1342.
Loo, V. G., Richardson, S., & Quinn, P. (1991). Isolation of Mycoplasma pneumoniae from pleural fluid. Diagn. Microbiol. Infect. Dis., 14, 443–445.
Mansel, J. K., Rosenow, E. C. III, Smith, T. F, & Martin, J. W. Jr. (1989). Mycoplasma pneumoniae pneumonia. Chest, 95, 639–646.
Marmion, B. P., Williamson, J., Worswick, D. A., Kok, T.-W., & Harris, R. J. (1993). Experience with newer techniques for the laboratory detection of Mycoplasma pneumoniae infection: Adelaide, 1978–1992. Clin. Infect. Dis., 17(Suppl. 1), S90–S99.
Marrie, T. J. (1993). Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch. Intern. Med., 153, 488–494.
Marrie, T. J. (1996). Atypical pneumonia revisited. Semin. Respir. Crit. Care Med., 17, 221–229.
Marrie, T. J., Durent, H., & Yates, L. (1989). Community-acquired pneumonia requiring hospitalization: 5 year prospective study. Rev. Infect. Dis., 11, 586–599.
Marrie, T. J., Peeling, R. W., Fine, M. J., Singer, D. E., Coley, C. M., & Kapoor, W. N. (1996). Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am. J. Med., 101, 508–515.
Marston, B. J., Plouffe, J. F., File, T. M. Jr., Hackman, B. A., Salstrom, S.-J., Lipman, H. B., Kolczak, M. S., & Breiman, R. F., for the Community-Based Pneumonia Incidence Study Group. (1997). Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch. Intern. Med., 157, 1709–1718.
McCormak, W. M. (1993). Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin. Infect. Dis., 17(Suppl. 1), S200–S20I.
McCracken, G. H. Jr. (1986). Current status of antibiotic treatment for Mycoplasma pneumoniae infections. Pediatr. Infect. Dis., 5, 167–171.
McMillan, J. (1998). Mycoplasma pneumoniae, in: Antimicrobial Therapy and Vaccines (V. Yu, T. G. Merigan, & S. Barriere, eds.). Baltimore: Williams & Wilkins, pp. 593–595.
Mundy, L. M., Auwaerter, P. G., Oldach, D., Warner, M. L., Burton, A., Vance, E., Gaydos, C. A., Joseph, J. M., Gopalan, R., Moore, R. D., Quinn, T. C., Charache, P., & Bartlett, J. G. (1995). Community-acquired pneumonia impact of immune status. Am. J. Respir. Crit. Cure Med., 152, 1309–1315.
Murray, H. W., Masur, H., Senterfit, L. B., & Roberts, R. B. (1975). The protean manifestations of Mycoplasma pneumoniae infection in adults. Am. J. Med., 58, 229–241.
Nagayama, Y., Sakurai, N., Tamai, K., Niwa, A., & Yamamoto, K. (1987). Isolation of Mycoplasma pneumoniae from pleural fluid and/or cerebrospinal fluid: report of four cases. Scand. J. Infect. Dis., 19, 521–524.
Narita, M., Matsuzono, Y., Itakura, O., Yamada, S., & Togashi, T. (1998). Analysis of mycoplasmal pleural effusion by the polymerase chain reaction. Arch. Dis. Child., 78, 67–69.
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993). Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis., 148, 1418–1426.
Orlieck, S. L., Walker, M. S., & Kuhls, T. L. (1992). Severe Mycoplasma pneumonia in young children with Down syndrome. Clin. Pediatr., 31, 409.
Pellegrini, M., O’Brien, T. J., Hoy, J., & Sedal, L. (1996). Mycoplasma pneumoniae infection associated with an acute brainstem syndrome. Ada Neurol. Scand., 93, 203–206.
Perez., C. R., & Leigh, M. W. (1991). Mycoplasma pneumoniae as the causative agent for pneumonia in the immunocompromised host. Chest, 100, 860–861.
Perez, C., Mendoza, H., Hernandez., R., Valcayo, A., & Guarch, R. (1997). Leukocytoclastic vasculitis and polyarthritis associated with Mycoplasma pneumoniae infection. Clin. Infect. Dis., 25, 154–155.
Plouffe, J. F., Herbert, M. T, File, T. M. Jr., Baird, I., Parsons, J. N., Kahn, J. B., Rielly-Gauvin, K. T, & the Pneumonia Study Group. (1996). Ofloxacin versus standard therapy in the treatment of community-acquired pneumonia requiring hospitalization. Antimicrob. Agents Chemother., 40, 1175–1179.
Plouffe, J. F, Niederman, M. S., Greenberg, R. N., Nelson, M., Kotschwar, T, Barone, J., & Kolokathis, A. (2000). Safety of IV/oral azithromycin (AZ) versus cefuroxime (C) ± erythromycin (E) in patients with community-acquired pneumonia (CAP). Antimicrob. Agents. Chemother., 44, 1796–1802.
Pönkä, A. (1979). Arthritis associated with Mycoplasma pneumoniae infection. Scand. J. Rheumatol., 8, 27–32.
Quinn, T. C. (1996). Diagnosis of atypical pneumonias: Legionella, Chlamydia, and Mycoplasma infections, in: The Laboratory Evaluation of Opportunistic Pulmonary Infections (J. H. Shelhamer, V. J. Gill, T. C. Quinn, S. W. Crawford, J. A. Kovacs, & H. Masur, eds.). Ann. Intern. Med., 124, 585–599.
Ramirez, J. A., Ahkee, S., Tolentino, A., Miller, R. D., & Summersgill, J. T. (1996). Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using polymerase chain reaction on a single throat swab specimen. Diagn. Microbiol. Infect. Dis., 24, 7–14.
Renaudin, H., & Bébéar, C. (1990). Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. Eur. J. Clin. Microhiol. Infect. Dis., 9, 838–841.
Ridgeway, G. L., Salman, H., Robbins, M. J., Dancer, C., & Felmingham, D. (1997). The in vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma and Legionella spp. Antimicrob. Chemother., 40(Suppl. A), 31–34.
Rieman, H. A. (1938). An acute infection of the respiratory tract with atypical pneumonia. JAMA, 26, 2377–2384.
Shames, J. M., George, R. B., Holliday, W. B., Rasch, J. R., & Mogabgab, W. J. (1970). Comparison of antibiotics in the treatment of Mycoplasma pneumonia. Arch. Intern. Med., 125, 680–684.
Shulman, S. T., Barlett, J., Clyde, W. A., & Ayoub, E. M. (1972). The unusual severity of mycoplasmal pneumonia in children with sickle-cell disease. N. Engl. J. Med., 287, 164.
Smith, C. B., Friedwell, W. T, & Chanock, R. M. (1967). Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin. N. Engl. J. Med., 276, 1172–1175.
Solanki, D. L., & Berdoff, R. L. (1979). Severe mycoplasma pneumonia with pleural effusions in a patient with sickle cell-hemoglobin C (SC) disease. Am. J. Med., 66, 707.
Talkington, D. F., Thacker, W. L., Keller, D. W., & Jensen J. S. (1998). Diagnosis of Mycoplasma pneumoniae infection in autopsy and open-lung biopsy tissues by nested PCR. J. Clin. Microb., 36, 1151–1153.
Tjhie, J. H. T, VanDePutte, E. M., Haasnoot, K., Van DenBrule, A. J. C., & Vandenbroucke-Grauls, C. M. J. E. (1997). Fatal encephalitis caused by Mycoplasma pneumoniae in a 9-year-old girl. Scand. J. Infect. Dis., 29, 424–425.
Wubbel, L., Jafri, H. S., Olsen, K., Shelton, S., Rogers, B. B., Gambill, G., Patel, P., Keyser, E., Cassell, G., & McCracken, G. H. (1998). Mycoplasma pneumoniae pneumonia in a mouse model. J. Infect. Dis., 178, 1526–1529.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
File, T.M., Tan, J.S. (2002). Mycoplasma pneumoniae Pneumonia. In: Marrie, T.J. (eds) Community-Acquired Pneumonia. Springer, Boston, MA. https://doi.org/10.1007/0-306-46834-4_30
Download citation
DOI: https://doi.org/10.1007/0-306-46834-4_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46432-4
Online ISBN: 978-0-306-46834-6
eBook Packages: Springer Book Archive